SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

NCT05552807 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Squamous Carcinoma

Interventions

DRUG: SCT-I10A
DRUG: SCT200
DRUG: paclitaxel
DRUG: docetaxel

Sponsor

Sinocelltech Ltd.